Literature DB >> 20865895

Rocuronium and sugammadex in myotonic dystrophy.

P Baumgartner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20865895

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN： 0310-057X            Impact factor:   1.669


× No keyword cloud information.
  5 in total

1.  The successful use of sugammadex and uneventful recovery from general anaesthesia in a patient with myotonic dystrophy.

Authors:  Usha Gurunathan; Gemma Duncan
Journal:  Indian J Anaesth       Date:  2015-05

Review 2.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

3.  Use of Sugammadex in a Patient With Myotonic Dystrophy.

Authors:  Samira Ahmed; Aymen Naguib; Dmitry Tumin; Joseph D Tobias
Journal:  Cardiol Res       Date:  2018-02-11

4.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217

5.  [Opioid-free general anesthesia and induced recovery from anesthesia in a patient with myotonic dystrophy type-1: a case report].

Authors:  Hande Gurbuz; Kemal Tolga Saracoglu
Journal:  Braz J Anesthesiol       Date:  2020-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.